Voyager Therapeutics stock trades at EUR 1.59 on Thursday

Company: Voyager Therapeutics, Inc.
ISIN: US92915B1061
Trading venue: Lang & Schwarz
Quote: 1.59 euros at 14:03 CET on Thursday, November 12, 2026

Published on 11/12/2026 at 14:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Voyager Therapeutics stock remained in focus during Thursday trading. The biotechnology company develops genetic medicines for neurological conditions.

Voyager Therapeutics remains in focus

The biotechnology company is active in genetic medicine development.
Its pipeline includes programs targeting neurological disease.

VYGR, US92915B1061, Illustration mit AI erstellt.

Voyager Therapeutics stock traded at 1.59 euros on Lang & Schwarz at 14:03 CET on Thursday, November 12, 2026.

Genetic medicine remains central

Voyager Therapeutics is a biotechnology company active in genetic medicine development. Its pipeline includes programs targeting neurological disease, keeping clinical progress central to the investment case.